Application of a new spectral deconvolution method for in vitro dosimetry in assessment of targeted alpha therapy - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Medical Physics Année : 2023

Application of a new spectral deconvolution method for in vitro dosimetry in assessment of targeted alpha therapy

Résumé

BackgroundThe improvement of in vitro assessment of targeted alpha therapy (reproducibility, comparability of experiments horizontal ellipsis ) requires precise evaluation of the dose delivered to the cells. To answer this need, a previous study proposed an innovative dosimetry method based on alpha-spectroscopy and a specific deconvolution process to recover the spatial distribution of Pb-212 isotopes inside in vitro culture wells. Nevertheless, although promising, the deconvolution method was time consuming and only tested for a simple isotope decay chain. PurposeThe purpose of this work is to propose a new matrix deconvolution method of alpha spectra based on a constrained-non-negative-maximum-likelihood decomposition, both faster and offering a greater modelling flexibility, allowing to study independently the kinetics of each of the daughter nuclides of complex decay chains (illustrated here with Ra-223) in in vitro culture wells. MethodsFirstly, the performance of the new method was fully evaluated through Monte Carlo simulations of in vitro irradiations. Different spatial distributions of Pb-212 and Ra-223, the corresponding alpha spectra measured by a silicon detector and the doses delivered to the cells were simulated with Geant4. The deconvolution results were then compared to the simulation results. Secondly, measurements were carried out in culture wells without cells containing 15 kBq of Pb-212 or 9.3 kBq of Ra-223, placed above silicon detectors recording alpha spectra in real time. The matrix deconvolution was then applied to determine the spatial and temporal distribution of all alpha-emitting daughters of studied isotopes. ResultsThe matrix deconvolution was proved to recover the simulated distribution gradients, ensuring simulated doses within 3 % for both tested radionuclides, with errors on dose normally distributed around the reference value (consequently not exhibiting any bias), even in the case of complex decay chains as Ra-223. The experimental study of Pb-212 and Ra-223 showed highly inhomogeneous distributions and time evolution of the concentration gradients, consistent with the previous study. Furthermore, it highlighted the complex kinetics of Ra-223 with different distributions of its alpha-emitting daughters (Rn-219, Po-215, At-215, Bi-211, Po-211). ConclusionsThis study validates a new deconvolution method, fast and flexible, that proved to be accurate and reliable. This method allowed to reveal the complexity of isotopes kinetics in in vitro experiments, especially with complex decay chains. Experimental dosimetry, necessary to improve reliability of in vitro studies in targeted alpha therapy, is demonstrated to be feasible with the proposed method.
Fichier principal
Vignette du fichier
2023_Doudard_MedicalPhysics.pdf (1.71 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04042586 , version 1 (19-10-2023)

Identifiants

Citer

Alexis Doudard, Aurélien Corroyer-Dulmont, Cyril Jaudet, Myriam Bernaudin, Samuel Valable, et al.. Application of a new spectral deconvolution method for in vitro dosimetry in assessment of targeted alpha therapy. Medical Physics, 2023, 50 (6), pp.3762-3772. ⟨10.1002/mp.16279⟩. ⟨hal-04042586⟩
49 Consultations
17 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More